Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.
An expression vector was constructed that carries part of the human BK papovavirus with 0.5 kilobases of (2'-5')oligoadenylate (2-5A) synthetase cDNA inserted in inverted orientation downstream from the virion proteins (VP) promoter and the neomycin-resistance gene neo under the control of a simian virus 40 promoter. Cells transfected with this vector and selected for resistance to the neomycin derivative G418 synthesized RNA complementary to 2-5A synthetase mRNA. These cells lacked 2-5A synthetase activity, and the enzyme was not inducible by interferon. In contrast, 2-5A synthetase was induced in cells transfected with a control vector without the cDNA insert. Such cells were protected by interferon from RNA viruses, whereas cells lacking 2-5A synthetase were not protected from encephalomyocarditis virus, vesicular stomatitis virus, and Sindbis virus but were fully protected from influenza virus. These findings show that a high level of 2-5A synthetase is required for interferon-induced protection from the cytoplasmic RNA viruses tested.
D015088:2',5'-Oligoadenylate Synthetase / Q000235:genetics*; D001739:BK Virus / Q000201:enzymology / Q000235:genetics*; D002460:Cell Line; D004247:DNA / Q000378:metabolism; D005822:Genetic Vectors; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D012516:Osteosarcoma; D011120:Polyomavirus / Q000235:genetics*; D012313:RNA / Q000235:genetics*; D018075:RNA, Complementary; D013045:Species Specificity; D014158:Transcription, Genetic / Q000187:drug effects*; D014162:Transfection; D014780:Viruses / Q000187:drug effects
D007370:Interferon Type I; D018075:RNA, Complementary; D012313:RNA; D004247:DNA; D015088:2',5'-Oligoadenylate Synthetase